β-tubulin III and IV expression as predictive factors for overall survival after paclitaxet therapy in patients with heavily pre-treated metastatic breast cancer.

被引：0
|
作者：
Kendzierski, N.
Mangia, A.
Ulbrich, E. J.
Strauss, H. G.
Thomssen, C.
Paradiso, A.
机构：
[1] Univ Halle Wittenberg, Halle, Germany
[2] Natl Canc Inst, Bari, Italy
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [1] Prognostic and predictive factors of eribulin in patients with heavily pre-treated metastatic breast cancer
    Chen, Pei-Hsin
    Yeh, Dah-Cherng
    Tung, Heng-Hsin
    Lin, Chin-Yao
    MEDICINE, 2021, 100 (47)
  • [2] Increased survival for heavily pre-treated metastatic breast cancer
    Siddall, Rhonda
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (07) : 370 - 370
  • [3] Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
    Rupert Bartsch
    Catharina Wenzel
    Simon P. Gampenrieder
    Ursula Pluschnig
    Gabriela Altorjai
    Margaretha Rudas
    Robert M. Mader
    Peter Dubsky
    Andrea Rottenfusser
    Michael Gnant
    Christoph C. Zielinski
    Guenther G. Steger
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 903 - 910
  • [4] Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
    Bartsch, Rupert
    Wenzel, Catharina
    Gampenrieder, Simon P.
    Pluschnig, Ursula
    Altorjai, Gabriela
    Rudas, Margaretha
    Mader, Robert M.
    Dubsky, Peter
    Rottenfusser, Andrea
    Gnant, Michael
    Zielinski, Christoph C.
    Steger, Guenther G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 903 - 910
  • [5] TREATMENT WITH ERIBULIN (HALAVEN) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC BREAST CANCER
    Lynge, M.
    Liposits, G. I.
    Linnet, S.
    Langkjer, S. T.
    BREAST, 2013, 22 : S43 - S43
  • [6] Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer
    Rasmussen, Maja Lynge
    Liposits, Gabor
    Yogendram, Subethini
    Jensen, Anders Bonde
    Linnet, Soren
    Langkjer, Sven Tyge
    ACTA ONCOLOGICA, 2014, 53 (09) : 1275 - +
  • [7] Successful ethinylestradiol therapy for a metastatic breast cancer patient with heavily pre-treated with endocrine therapies
    Aiko Sueta
    Mitsuhiro Hayashi
    Yoshiyuki Fukugawa
    Hirokazu Shimizu
    Mutsuko Yamamoto-Ibusuki
    Yutaka Yamamoto
    Hirotaka Iwase
    International Cancer Conference Journal, 2016, 5 (3) : 126 - 130
  • [8] Successful ethinylestradiol therapy for a metastatic breast cancer patient with heavily pre-treated with endocrine therapies
    Sueta, Aiko
    Hayashi, Mitsuhiro
    Fukugawa, Yoshiyuki
    Shimizu, Hirokazu
    Yamamoto-Ibusuki, Mutsuko
    Yamamoto, Yutaka
    Iwase, Hirotaka
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2016, 5 (03): : 126 - 130
  • [9] Temozolimide and capecitabine in heavily pre-treated patients with KRASmut metastatic colorectal cancer. A phase II trial
    Qvortrup, C.
    Keldsen, N.
    Andersen, F.
    Jensen, H. A.
    Krogh, M.
    Vestermark, L. W.
    Christensen, G.
    Bjerregaard, J. K.
    Pfeiffer, P.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S380 - S380
  • [10] Impact of Itraconazole on the Survival of Heavily Pre-treated Patients with Triple-Negative Breast Cancer
    Tsubamoto, Hiroshi
    Sonoda, Takashi
    Inoue, Kayo
    ANTICANCER RESEARCH, 2014, 34 (07) : 3839 - 3844
12345